Chainlink, Plexos и EDinheiro поддержат бразильскую социальную блокчейн-валюту

cryptonews.ru2025-05-30 tarihinde yayınlandı2025-07-31 tarihinde güncellendi

Chainlink присоединилась к институту Plexos и платформе EDinheiro в проекте по расширению финансового доступа в Бразилии через локально выпускаемые социальные валюты на базе блокчейна. Партнеры будут работать в г. Индиароба, штат Сержипи и запустят валюту Aratu. Aratu будут пользоваться около 18 000 местных жителей, которые зарабатывают на жизнь сбором моллюсков и не имеют доступа к финансовым услугам.

Социальные валюты выпускаются муниципальными или общественными банками и используются для локальных платежей и распределения помощи. Платформа EDinheiro, уже поддерживающая более 180 таких валют по всей Бразилии, будет отвечать за выпуск и управление Aratu. Технология Chainlink обеспечит безопасные связи между локальными информационными системами и блокчейн-инфраструктурой, позволяя автоматизировать отчетность, аудит и соответствие требованиям законодательства о защите данных в Бразилии.

Проект является официальным примером применения в рамках Blockchain Brazil Network (RBB) государственной инфраструктуры, созданной Федеральной Счетной палатой и Национальным банком развития. Цель RBB — повысить прозрачность и эффективность государственных программ. Институт Plexos является ассоциированным участником сети и валидатором.

Благодаря технологиям безопасности и подключения от Chainlink партнеры рассчитывают сделать социальные валюты более прозрачными и удобными в управлении. Инициатива в Индиаробе должна стать моделью для аналогичных программ в других регионах, помогая местным властям эффективно распределять помощь и стимулировать экономическую активность в малообеспеченных сообществах.

Изображение: Freepik

Trend Kriptolar

İlgili Okumalar

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

On August 18th, Haowei Huaxin, a semiconductor firm specializing in gallium arsenide and gallium nitride wafers, reported that over a hundred individuals forcibly entered its offices and seized the company's official seals from a safe, including the corporate, contract, and party committee seals. The incident is the latest escalation in a protracted control dispute. Haowei Huaxin, established in 2010, was originally a joint venture. Control became contested after 2021 when Zhenwei Financial Holding injected capital, becoming the largest shareholder (34.01%), while former parent Haite High-Tech's stake was diluted to 33.79%. An agreed-upon governance structure collapsed, leading to mutual accusations. Haite claimed it was locked out of the subsidiary's premises, while also alleging improper management like livestock being kept on the chip fabrication site. After state-owned Qingdao Haiyue Holdings took over Zhenwei's stake in 2023, Haite accused it of illegally seizing control. Despite Haite winning several legal battles in 2024-2026, which affirmed its rights to nominate directors and the chairman, it failed to regain physical control or recover the seals. The stakes are high: market valuations for Haite's stake in Haowei Huaxin are estimated between 3.7 to 5 billion USD, yet it is only valued at about 83 million USD on Haite's books. Losing control effectively jeopardizes a significant portion of Haite's value. In response to the seal seizure, Haite framed it as a "shareholder rights protection" action agreed upon by five shareholders. This mirrors a pattern in Chinese corporate disputes where seizing physical seals becomes a tactic to paralyze the opponent's daily operations, seen in past conflicts at companies like Dangdang and Bitmain. However, such actions don't resolve underlying ownership issues; the opposing party can report the seals stolen, declare them void, and apply for new ones, albeit with significant delay. The incident underscores how fragile corporate governance can devolve into physical confrontations over symbols of authority, with control ultimately determined by law and shareholding, not possession of a seal.

marsbit23 dk önce

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

marsbit23 dk önce

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

Bernstein's analysis of Moderna's 177% stock surge following positive Phase 3 results for its individualized neoantigen therapy (INT) in melanoma distinguishes fundamental drivers from market speculation. The clinical breakthrough is real: the INTerpath-001 trial met its primary and key secondary endpoints, providing crucial validation for mRNA technology in oncology beyond infectious diseases. However, Bernstein argues the magnitude of the stock move cannot be justified by this single trial's fundamentals alone. The surge was amplified by three key factors: 1) A re-rating of Moderna's mRNA platform potential for expansion into other cancers, 2) A massive short squeeze, given ~15% of shares were sold short pre-announcement, and 3) The compelling "cancer vaccine" narrative that fueled broader investor enthusiasm. While the melanoma success is significant, Bernstein cautions that replication in lung, kidney, and bladder cancers—which have different immunogenicity—is not guaranteed. Furthermore, INT's commercial model faces challenges: it's a personalized treatment, not a mass-market vaccine, implying higher production costs and potential margin pressures despite a projected multi-billion dollar peak sales opportunity. The report also notes sector rotation, with some funds moving from crowded AI/semiconductor trades into defensive healthcare stocks, adding further momentum. In conclusion, Bernstein maintains a "Market-Perform" rating and a $45 price target, far below the post-surge price. It views the current valuation as pricing in an optimistic multi-cancer platform success and efficient commercialization that are yet to be proven. The clinical inflection point is clear, but the earnings inflection point awaits validation across future trials and commercial execution.

marsbit24 dk önce

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

marsbit24 dk önce

İşlemler

Spot

Popüler Makaleler

LINK Nasıl Satın Alınır

HTX.com’a hoş geldiniz! ChainLink (LINK) satın alma işlemlerini basit ve kullanışlı bir hâle getirdik. Adım adım açıkladığımız rehberimizi takip ederek kripto yolculuğunuza başlayın. 1. Adım: HTX Hesabınızı OluşturunHTX'te ücretsiz bir hesap açmak için e-posta adresinizi veya telefon numaranızı kullanın. Sorunsuzca kaydolun ve tüm özelliklerin kilidini açın. Hesabımı Aç2. Adım: Kripto Satın Al Bölümüne Gidin ve Ödeme Yönteminizi SeçinKredi/Banka Kartı: Visa veya Mastercard'ınızı kullanarak anında ChainLink (LINK) satın alın.Bakiye: Sorunsuz bir şekilde işlem yapmak için HTX hesap bakiyenizdeki fonları kullanın.Üçüncü Taraflar: Kullanımı kolaylaştırmak için Google Pay ve Apple Pay gibi popüler ödeme yöntemlerini ekledik.P2P: HTX'teki diğer kullanıcılarla doğrudan işlem yapın.Borsa Dışı (OTC): Yatırımcılar için kişiye özel hizmetler ve rekabetçi döviz kurları sunuyoruz.3. Adım: ChainLink (LINK) Varlıklarınızı SaklayınChainLink (LINK) satın aldıktan sonra HTX hesabınızda saklayın. Alternatif olarak, blok zinciri transferi yoluyla başka bir yere gönderebilir veya diğer kripto para birimlerini takas etmek için kullanabilirsiniz.4. Adım: ChainLink (LINK) Varlıklarınızla İşlem YapınHTX'in spot piyasasında ChainLink (LINK) ile kolayca işlemler yapın.Hesabınıza erişin, işlem çiftinizi seçin, işlemlerinizi gerçekleştirin ve gerçek zamanlı olarak izleyin. Hem yeni başlayanlar hem de deneyimli yatırımcılar için kullanıcı dostu bir deneyim sunuyoruz.

1.0k Toplam GörüntülenmeYayınlanma 2024.12.13Güncellenme 2026.06.02

LINK Nasıl Satın Alınır

Tartışmalar

HTX Topluluğuna hoş geldiniz. Burada, en son platform gelişmeleri hakkında bilgi sahibi olabilir ve profesyonel piyasa görüşlerine erişebilirsiniz. Kullanıcıların LINK (LINK) fiyatı hakkındaki görüşleri aşağıda sunulmaktadır.

活动图片